Diagnostic Medical Systems S.A.
ALDMS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 1.6% | 1.5% | 2,220% | – |
| Cost of Goods Sold | €0 | €0 | €0 | -€0 |
| Gross Profit | €0 | €0 | -€0 | €0 |
| % Margin | 0% | 81.5% | -2.3% | 869.8% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | -€0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | -€0 | €0 | -€0 | -€0 |
| % Margin | -9.3% | 1.6% | -3.1% | -136.3% |
| Other Income/Exp. Net | €0 | €0 | -€0 | €0 |
| Pre-Tax Income | €0 | -€0 | -€0 | -€0 |
| Tax Expense | €0 | €0 | €0 | €0 |
| Net Income | -€0 | -€0 | -€0 | €0 |
| % Margin | -0.4% | -6.5% | -6.3% | 488.6% |
| EPS | -0.011 | -0.081 | -0.089 | -0.81 |
| % Growth | 86.8% | 8.7% | 89% | – |
| EPS Diluted | -0.011 | -0.081 | -0.089 | -0.81 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€0 | -€0 | €0 | -€0 |
| % Margin | -4.2% | -99.9% | 1.1% | -65.1% |